Saturday, April 12, 2025

Technology | 2018.09.10

InMed Files Patent Application for its Cannabinoid Biosynthesis Program

TSX:IN OTCQX:IMLFF VANCOUVER, Sept. 10, 2018 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary biosynthesis platform technology to develop novel...

 

For more information, please visit
https://www.prnewswire.com:443/news-rele[...]nthesis-program-300708576.html

You need to login to post comments.

Feed last updated 2025/04/30 @8:04 AM

0 COMMENTS:

Follow us on Follow Us on Facebook Follow Us on Twitter
©2006 Translations News